Spectrum Science Acquires Continuum Clinical
February 8, 2024
Spectrum Science has acquired Continuum Clinical from Blue Chip Worldwide to strengthen its clinical trial recruitment (CTR) capabilities. Continuum will merge into Spectrum’s CTR strategic pillar—bringing its MERIS technology, a large client roster, and leadership under Neil Weisman—creating a combined team of more than 130 clinical solutions specialists; financial terms were not disclosed.
- Buyers
- Spectrum Science
- Targets
- Continuum Clinical
- Sellers
- Blue Chip Worldwide
- Industry
- Healthcare Services
- Location
- Illinois, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.